Patents by Inventor Tae Nyoung CHUNG

Tae Nyoung CHUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220211762
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of sepsis or systemic inflammatory response syndrome (SIRS) comprising mitochondria as effective ingredient. When activated macrophages and monocytes are treated with mitochondria which are effective ingredient of the pharmaceutical composition of the present invention, expression of IL-1?, TNF-? and IL-6 which are pro-inflammatory cytokines can be restored to normal levels. Furthermore, when the pharmaceutical composition of the present invention is administered to a subject suffering from sepsis, the survival rate of the subject can be remarkably increased. Therefore, the pharmaceutical composition according to the present invention can be useful for the treatment of sepsis.
    Type: Application
    Filed: April 27, 2020
    Publication date: July 7, 2022
    Inventors: Kyuboem HAN, Chun-Hyung KIM, Shin-Hye YU, Seo-Eun LEE, Sang-Min LIM, Hahnsun JUNG, Kwangmin NA, Yoon Mi HAN, Jun Young SON, Jong-Cheon HA, Kyunghee JUNG, Young-Cheol KANG, Eun-Seo LEE, Mi Jin KIM, Yong-Soo CHOI, Jung Uk HWANG, Min Ji LEE, Kyuseok KIM, Tae Nyoung CHUNG